Tapewire

Nasdaq · USD

KURA

Kura Oncology, Inc.

Export transactions ↓
Tapewire entity
4871
SEC CIK
0001422143
Parsed reports
239

Last 12 months

Inside the activity.

2 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202502
Jan 2026016
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202601
Jul 202600
Aug 202622
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 24, 2020 Filed Jun 26, 2020 20:06 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039067 · doc4.xml · derivative · entry 1

HOFFMAN ROBERT · CIK 0001166288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 20:09 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039071 · doc4.xml · derivative · entry 1

Stein Steven H · CIK 0001673776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 20:11 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039076 · doc4.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 20:10 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039074 · doc4.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 20:08 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039070 · doc4.xml · derivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 20:07 UTC GrantOption to purchase common stock · Derivative 23,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001209191-20-039068 · doc4.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2030-06-23

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
March 12, 2020 Filed Mar 18, 2020 00:19 UTC
BASTA JAMESChief Legal Officer
GrantOption to purchase common stock · Derivative 25,000 $0.00 Strike: $8.41 $0.00
Disclosure

SEC source: 0001209191-20-019830 · doc4.xml · derivative · entry 1

BASTA JAMES · CIK 0001792726 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-03-11

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
February 11, 2020 Filed Feb 12, 2020 21:24 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionOption to purchase common stock · Derivative 26,911 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001209191-20-008732 · doc4.xml · derivative · entry 6

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,063

Underlying: Common stock · 26,911 shares

Expires 2026-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised.

F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on 1/29/2016.

Read SEC document
February 11, 2020 Filed Feb 12, 2020 21:24 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionOption to purchase common stock · Derivative 1,185 $0.00 Strike: $6.15 $0.00
Disclosure

SEC source: 0001209191-20-008732 · doc4.xml · derivative · entry 5

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,815

Underlying: Common stock · 1,185 shares

Expires 2027-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised.

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on 1/23/2017.

Read SEC document
February 11, 2020 Filed Feb 12, 2020 21:24 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionCommon stock 26,911 $4.80 $129,172.80
Disclosure

SEC source: 0001209191-20-008732 · doc4.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised.

Read SEC document
February 11, 2020 Filed Feb 12, 2020 21:24 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionCommon stock 1,185 $6.15 $7,287.75
Disclosure

SEC source: 0001209191-20-008732 · doc4.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,226

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:22 UTC
Martell Bridget AActing Chief Medical Officer
GrantOption to purchase common stock · Derivative 50,000 $0.00 Strike: $12.22 $0.00
Disclosure

SEC source: 0001209191-20-008730 · doc4.xml · derivative · entry 2

Martell Bridget A · CIK 0001629627 · Acting Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-02-09

F2 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the date of grant, and 1/48th of the shares vest in 36 monthly installments thereafter.

Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:22 UTC
Martell Bridget AActing Chief Medical Officer
GrantOption to purchase common stock · Derivative 50,000 $0.00 Strike: $12.22 $0.00
Disclosure

SEC source: 0001209191-20-008730 · doc4.xml · derivative · entry 1

Martell Bridget A · CIK 0001629627 · Acting Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-02-09

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantOption to purchase common stock · Derivative 393,950 $0.00 Strike: $11.86 $0.00
Disclosure

SEC source: 0001209191-20-005973 · doc4.xml · derivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,950

Underlying: Common Stock · 393,950 shares

Expires 2030-01-29

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 21:08 UTC
FORD KATHLEENChief Operating Officer
GrantOption to purchase common stock · Derivative 45,393 $0.00 Strike: $11.86 $0.00
Disclosure

SEC source: 0001209191-20-005979 · doc4.xml · derivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,393

Underlying: Common Stock · 45,393 shares

Expires 2030-01-29

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 21:07 UTC
GRASSO MARCCFO, CBO
GrantOption to purchase common stock · Derivative 111,723 $0.00 Strike: $11.86 $0.00
Disclosure

SEC source: 0001209191-20-005976 · doc4.xml · derivative · entry 1

GRASSO MARC · CIK 0001748894 · CFO, CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,723

Underlying: Common Stock · 111,723 shares

Expires 2030-01-29

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 06, 2020 Filed Jan 7, 2020 21:10 UTC
FLOWERS KIRSTENChief Commercial Officer
GrantOption to purchase common stock · Derivative 250,000 $0.00 Strike: $13.85 $0.00
Disclosure

SEC source: 0001209191-20-002242 · doc4.xml · derivative · entry 1

FLOWERS KIRSTEN · CIK 0001797209 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2030-01-05

F1 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter.

Read SEC document
November 04, 2019 Filed Nov 5, 2019 22:23 UTC
BASTA JAMESChief Legal Officer
GrantOption to purchase common stock · Derivative 175,000 $0.00 Strike: $15.36 $0.00
Disclosure

SEC source: 0001209191-19-055289 · doc4.xml · derivative · entry 1

BASTA JAMES · CIK 0001792726 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2029-11-03

F1 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:07 UTC GrantOption to purchase common stock · Derivative 8,666 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0001209191-19-053278 · doc4.xml · derivative · entry 2

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,666

Underlying: Common Stock · 8,666 shares

Expires 2029-10-13

F2 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 20:07 UTC GrantOption to purchase common stock · Derivative 30,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0001209191-19-053278 · doc4.xml · derivative · entry 1

Parks Diane L. · CIK 0001781026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2029-10-13

F1 · derivative.exercise_date: This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.

Read SEC document
August 09, 2019 Filed Aug 13, 2019 22:17 UTC
FORD KATHLEENChief Operating Officer
GrantOption to purchase common stock · Derivative 250,000 $0.00 Strike: $19.43 $0.00
Disclosure

SEC source: 0001209191-19-045803 · doc4.xml · derivative · entry 1

FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2029-08-08

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date of August 9, 2019.

Read SEC document
July 10, 2019 Filed Jul 12, 2019 20:04 UTC
GUALBERTO ANTONIOHead of Development & CMO
Exercise / conversionOption to purchase common stock · Derivative 18,000 $0.00 Strike: $6.15 $0.00
Disclosure

SEC source: 0001209191-19-041911 · doc4.xml · derivative · entry 3

GUALBERTO ANTONIO · CIK 0001635794 · Head of Development & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,000

Underlying: Common Stock · 18,000 shares

Expires 2027-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.

F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
July 10, 2019 Filed Jul 12, 2019 20:04 UTC
GUALBERTO ANTONIOHead of Development & CMO
SaleCommon Stock 18,000 $21.11 $379,902.60
Disclosure

SEC source: 0001209191-19-041911 · doc4.xml · nonDerivative · entry 2

GUALBERTO ANTONIO · CIK 0001635794 · Head of Development & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,973

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.10 to $21.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
July 10, 2019 Filed Jul 12, 2019 20:04 UTC
GUALBERTO ANTONIOHead of Development & CMO
Exercise / conversionCommon Stock 18,000 $6.15 $110,700.00
Disclosure

SEC source: 0001209191-19-041911 · doc4.xml · nonDerivative · entry 1

GUALBERTO ANTONIO · CIK 0001635794 · Head of Development & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.

Read SEC document
June 25, 2019 Filed Jun 27, 2019 20:05 UTC GrantOption to purchase common stock · Derivative 13,000 $0.00 Strike: $19.55 $0.00
Disclosure

SEC source: 0001209191-19-039240 · doc4.xml · derivative · entry 1

HOFFMAN ROBERT · CIK 0001166288 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2029-06-24

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 25, 2019 Filed Jun 27, 2019 20:09 UTC GrantOption to purchase common stock · Derivative 13,000 $0.00 Strike: $19.55 $0.00
Disclosure

SEC source: 0001209191-19-039244 · doc4.xml · derivative · entry 1

Stein Steven H · CIK 0001673776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common stock · 13,000 shares

Expires 2029-06-24

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 25, 2019 Filed Jun 27, 2019 20:10 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 13,000 $0.00 Strike: $19.55 $0.00
Disclosure

SEC source: 0001209191-19-039245 · doc4.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2029-06-24

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 25, 2019 Filed Jun 27, 2019 20:07 UTC GrantOption to purchase common stock · Derivative 13,000 $0.00 Strike: $19.55 $0.00
Disclosure

SEC source: 0001209191-19-039242 · doc4.xml · derivative · entry 1

Malley Thomas · CIK 0001403322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2029-06-24

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
June 25, 2019 Filed Jun 27, 2019 20:06 UTC GrantOption to purchase common stock · Derivative 13,000 $0.00 Strike: $19.55 $0.00
Disclosure

SEC source: 0001209191-19-039241 · doc4.xml · derivative · entry 1

Hasnain Faheem · CIK 0001352620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2029-06-24

F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:13 UTC
REN PINGDASVP Chemistry&Pharma Sciences
GrantOption to purchase common stock · Derivative 75,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005135 · doc4.xml · derivative · entry 1

REN PINGDA · CIK 0001635785 · SVP Chemistry&Pharma Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:11 UTC
North AnnetteSVP, General Counsel
GrantOption to purchase common stock · Derivative 100,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005134 · doc4.xml · derivative · entry 1

North Annette · CIK 0001341011 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:10 UTC
FARNAM JOHNChief Operating Officer
GrantOption to purchase common stock · Derivative 125,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005132 · doc4.xml · derivative · entry 1

FARNAM JOHN · CIK 0001744376 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:08 UTC
GRASSO MARCCFO, CBO
GrantOption to purchase common stock · Derivative 140,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005131 · doc4.xml · derivative · entry 1

GRASSO MARC · CIK 0001748894 · CFO, CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:07 UTC
GUALBERTO ANTONIOHead of Development & CMO
GrantOption to purchase common stock · Derivative 140,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005130 · doc4.xml · derivative · entry 1

GUALBERTO ANTONIO · CIK 0001635794 · Head of Development & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
January 22, 2019 Filed Jan 24, 2019 21:06 UTC
WILSON TROY EDWARDDirector · President and CEO
GrantOption to purchase common stock · Derivative 220,000 $0.00 Strike: $15.47 $0.00
Disclosure

SEC source: 0001209191-19-005129 · doc4.xml · derivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,000

Underlying: Common Stock · 220,000 shares

Expires 2029-01-21

F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date.

Read SEC document
December 21, 2018 Filed Jan 10, 2019 23:32 UTC PurchaseCommon Stock 83,540 $13.16 $1,099,386.40
Disclosure

SEC source: 0001567619-19-000984 · doc1.xml · nonDerivative · entry 4

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,408,097

Read SEC document
December 19, 2018 Filed Jan 10, 2019 23:32 UTC PurchaseCommon Stock 51,879 $13.84 $718,005.36
Disclosure

SEC source: 0001567619-19-000984 · doc1.xml · nonDerivative · entry 3

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,324,557

Read SEC document
December 18, 2018 Filed Jan 10, 2019 23:32 UTC PurchaseCommon Stock 78,469 $13.82 $1,084,441.58
Disclosure

SEC source: 0001567619-19-000984 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,272,678

Read SEC document
December 17, 2018 Filed Jan 10, 2019 23:32 UTC SaleCommon Stock 26,520 $13.20 $350,064.00
Disclosure

SEC source: 0001567619-19-000984 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,194,209

Read SEC document
December 13, 2018 Filed Dec 13, 2018 23:26 UTC PurchaseCommon Stock 25,217 $13.89 $350,264.13
Disclosure

SEC source: 0001567619-18-007956 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,220,729

Read SEC document
December 11, 2018 Filed Dec 13, 2018 23:26 UTC PurchaseCommon Stock 15,321 $13.91 $213,098.26
Disclosure

SEC source: 0001567619-18-007956 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,195,512

Read SEC document
December 06, 2018 Filed Dec 7, 2018 00:14 UTC PurchaseCommon Stock 17,079 $13.49 $230,395.71
Disclosure

SEC source: 0001567619-18-007453 · doc1.xml · nonDerivative · entry 3

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,180,919

Read SEC document
December 04, 2018 Filed Dec 7, 2018 00:14 UTC PurchaseCommon Stock 54,645 $13.08 $714,756.60
Disclosure

SEC source: 0001567619-18-007453 · doc1.xml · nonDerivative · entry 2

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,163,112

Read SEC document
December 03, 2018 Filed Dec 7, 2018 00:14 UTC PurchaseCommon Stock 48,182 $13.97 $673,102.54
Disclosure

SEC source: 0001567619-18-007453 · doc1.xml · nonDerivative · entry 1

EcoR1 Capital Fund Qualified, L.P. · CIK 0001598292 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,108,467

Read SEC document
November 16, 2018 Filed Jan 22, 2019 21:16 UTC
WILSON TROY EDWARDDirector · President and CEO
GiftCommon Stock 32,985 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-004733 · doc5.xml · nonDerivative · entry 2

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Red Fish Blue Fish Revocable Trust

Disclosed balance after: 1,768,976

F1 · kind: This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the purchase or sale of securities.

Read SEC document
November 16, 2018 Filed Jan 22, 2019 21:16 UTC
WILSON TROY EDWARDDirector · President and CEO
GiftCommon Stock 32,985 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-004733 · doc5.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,041

F1 · kind: This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the purchase or sale of securities.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 19:18 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 7,583 $0.00 Strike: $11.55 $0.00
Disclosure

SEC source: 0001209191-18-057721 · doc4.xml · derivative · entry 2

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,583

Underlying: Common Stock · 7,583 shares

Expires 2028-11-05

F2 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 19:18 UTC
Szela Mary TDirector
GrantOption to purchase common stock · Derivative 30,000 $0.00 Strike: $11.55 $0.00
Disclosure

SEC source: 0001209191-18-057721 · doc4.xml · derivative · entry 1

Szela Mary T · CIK 0001410289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-11-05

F1 · derivative.exercise_date: This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.

Read SEC document
November 06, 2018 Filed Nov 9, 2018 21:03 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionOption to purchase common stock · Derivative 26,041 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001209191-18-057931 · doc4.xml · derivative · entry 4

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,974

Underlying: Common stock · 26,041 shares

Expires 2026-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised

F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on 1/29/2016.

Read SEC document
November 06, 2018 Filed Nov 9, 2018 21:03 UTC
WILSON TROY EDWARDDirector · President and CEO
Exercise / conversionCommon Stock 26,041 $4.80 $124,996.80
Disclosure

SEC source: 0001209191-18-057931 · doc4.xml · nonDerivative · entry 1

WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents options exercised

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.